NL192500C - Magnesium bevattend toevoegsel voor voedingsmiddelen. - Google Patents

Magnesium bevattend toevoegsel voor voedingsmiddelen. Download PDF

Info

Publication number: NL192500C
Authority: NL; Netherlands
Prior art keywords: magnesium; lactate; citrate; salt; taste
Prior art date: 1987-09-28

Application number

NL8802383A

Other languages

English (en)

Dutch (nl)

Other versions

NL8802383A (nl

NL192500B (nl

Original Assignee

Collett Marwell Hauge As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-09-28

Filing date

1988-09-28

Publication date

1997-09-02

1988-09-28 Application filed by Collett Marwell Hauge As filed Critical Collett Marwell Hauge As

1989-04-17 Publication of NL8802383A publication Critical patent/NL8802383A/nl

1997-05-01 Publication of NL192500B publication Critical patent/NL192500B/xx

1997-09-02 Application granted granted Critical

1997-09-02 Publication of NL192500C publication Critical patent/NL192500C/nl

Links

239000011777 magnesium Substances 0.000 title claims description 55
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 title claims description 24
229910052749 magnesium Inorganic materials 0.000 title claims description 24
235000013373 food additive Nutrition 0.000 title claims description 7
239000002778 food additive Substances 0.000 title claims description 7
229940091250 magnesium supplement Drugs 0.000 claims description 24
159000000003 magnesium salts Chemical class 0.000 claims description 21
OVGXLJDWSLQDRT-UHFFFAOYSA-L magnesium lactate Chemical compound [Mg+2].CC(O)C([O-])=O.CC(O)C([O-])=O OVGXLJDWSLQDRT-UHFFFAOYSA-L 0.000 claims description 19
229960004658 magnesium lactate Drugs 0.000 claims description 19
239000000626 magnesium lactate Substances 0.000 claims description 19
235000015229 magnesium lactate Nutrition 0.000 claims description 19
PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 claims description 12
230000002378 acidificating effect Effects 0.000 claims description 11
229960005336 magnesium citrate Drugs 0.000 claims description 11
239000004337 magnesium citrate Substances 0.000 claims description 11
235000002538 magnesium citrate Nutrition 0.000 claims description 11
239000000203 mixture Substances 0.000 claims description 11
VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 claims description 9
239000000347 magnesium hydroxide Substances 0.000 claims description 9
229910001862 magnesium hydroxide Inorganic materials 0.000 claims description 9
150000001720 carbohydrates Chemical class 0.000 claims description 6
239000000654 additive Substances 0.000 claims description 4
230000000996 additive effect Effects 0.000 claims description 4
150000007524 organic acids Chemical class 0.000 claims description 4
239000011873 medical mixture Substances 0.000 claims description 2
239000008187 granular material Substances 0.000 description 26
235000002639 sodium chloride Nutrition 0.000 description 23
150000003839 salts Chemical class 0.000 description 21
235000019640 taste Nutrition 0.000 description 16
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 13
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 11
239000000796 flavoring agent Substances 0.000 description 11
235000019634 flavors Nutrition 0.000 description 11
108010011485 Aspartame Proteins 0.000 description 10
239000000605 aspartame Substances 0.000 description 10
IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 10
235000010357 aspartame Nutrition 0.000 description 10
229960003438 aspartame Drugs 0.000 description 10
238000005469 granulation Methods 0.000 description 10
230000003179 granulation Effects 0.000 description 10
239000007788 liquid Substances 0.000 description 10
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 10
206010013911 Dysgeusia Diseases 0.000 description 8
230000007935 neutral effect Effects 0.000 description 8
238000004519 manufacturing process Methods 0.000 description 7
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
239000002253 acid Substances 0.000 description 6
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
235000019658 bitter taste Nutrition 0.000 description 5
235000014633 carbohydrates Nutrition 0.000 description 5
230000000052 comparative effect Effects 0.000 description 5
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
229940069428 antacid Drugs 0.000 description 4
239000003159 antacid agent Substances 0.000 description 4
230000001458 anti-acid effect Effects 0.000 description 4
150000001875 compounds Chemical class 0.000 description 4
ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 4
239000001095 magnesium carbonate Substances 0.000 description 4
229910000021 magnesium carbonate Inorganic materials 0.000 description 4
229960003035 magnesium gluconate Drugs 0.000 description 4
239000001755 magnesium gluconate Substances 0.000 description 4
235000015778 magnesium gluconate Nutrition 0.000 description 4
IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 4
239000000243 solution Substances 0.000 description 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
230000000694 effects Effects 0.000 description 3
239000004615 ingredient Substances 0.000 description 3
229940074358 magnesium ascorbate Drugs 0.000 description 3
150000002681 magnesium compounds Chemical class 0.000 description 3
235000019341 magnesium sulphate Nutrition 0.000 description 3
AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 3
239000000600 sorbitol Substances 0.000 description 3
235000019614 sour taste Nutrition 0.000 description 3
235000000346 sugar Nutrition 0.000 description 3
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
206010012735 Diarrhoea Diseases 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
208000025371 Taste disease Diseases 0.000 description 2
TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
150000001450 anions Chemical class 0.000 description 2
239000011575 calcium Substances 0.000 description 2
229910052791 calcium Inorganic materials 0.000 description 2
235000003599 food sweetener Nutrition 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
229910052500 inorganic mineral Inorganic materials 0.000 description 2
239000008141 laxative Substances 0.000 description 2
230000002475 laxative effect Effects 0.000 description 2
229910001629 magnesium chloride Inorganic materials 0.000 description 2
239000000395 magnesium oxide Substances 0.000 description 2
CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
229910052943 magnesium sulfate Inorganic materials 0.000 description 2
AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 2
HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
235000019656 metallic taste Nutrition 0.000 description 2
238000000034 method Methods 0.000 description 2
235000010755 mineral Nutrition 0.000 description 2
239000011707 mineral Substances 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
239000011591 potassium Substances 0.000 description 2
229910052700 potassium Inorganic materials 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
239000003765 sweetening agent Substances 0.000 description 2
239000000811 xylitol Substances 0.000 description 2
HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
235000010447 xylitol Nutrition 0.000 description 2
229960002675 xylitol Drugs 0.000 description 2
DPZHKLJPVMYFCU-UHFFFAOYSA-N 2-(5-bromopyridin-2-yl)acetonitrile Chemical compound BrC1=CC=C(CC#N)N=C1 DPZHKLJPVMYFCU-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical group CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
MQHWFIOJQSCFNM-UHFFFAOYSA-L Magnesium salicylate Chemical compound [Mg+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O MQHWFIOJQSCFNM-UHFFFAOYSA-L 0.000 description 1
206010048886 Onychoclasis Diseases 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
208000003217 Tetany Diseases 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
235000002017 Zea mays subsp mays Nutrition 0.000 description 1
239000002250 absorbent Substances 0.000 description 1
230000002745 absorbent Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
206010003549 asthenia Diseases 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
150000001735 carboxylic acids Chemical class 0.000 description 1
235000009508 confectionery Nutrition 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000001816 cooling Methods 0.000 description 1
235000005822 corn Nutrition 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
235000015872 dietary supplement Nutrition 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
239000004744 fabric Substances 0.000 description 1
206010016256 fatigue Diseases 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
238000001914 filtration Methods 0.000 description 1
238000009472 formulation Methods 0.000 description 1
210000001156 gastric mucosa Anatomy 0.000 description 1
239000000174 gluconic acid Substances 0.000 description 1
235000012208 gluconic acid Nutrition 0.000 description 1
239000008103 glucose Substances 0.000 description 1
238000001631 haemodialysis Methods 0.000 description 1
230000000322 hemodialysis Effects 0.000 description 1
230000007794 irritation Effects 0.000 description 1
239000008101 lactose Substances 0.000 description 1
235000021056 liquid food Nutrition 0.000 description 1
244000144972 livestock Species 0.000 description 1
235000001055 magnesium Nutrition 0.000 description 1
UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
239000011654 magnesium acetate Substances 0.000 description 1
235000011285 magnesium acetate Nutrition 0.000 description 1
229940069446 magnesium acetate Drugs 0.000 description 1
229960001983 magnesium aspartate Drugs 0.000 description 1
229940031958 magnesium carbonate hydroxide Drugs 0.000 description 1
235000013918 magnesium diglutamate Nutrition 0.000 description 1
229940063886 magnesium glutamate Drugs 0.000 description 1
QWLHYYKDLOVBNV-UHFFFAOYSA-L magnesium orotate Chemical compound [Mg+2].[O-]C(=O)C1=CC(=O)NC(=O)N1.[O-]C(=O)C1=CC(=O)NC(=O)N1 QWLHYYKDLOVBNV-UHFFFAOYSA-L 0.000 description 1
229960000407 magnesium orotate Drugs 0.000 description 1
GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
239000004137 magnesium phosphate Substances 0.000 description 1
229960002261 magnesium phosphate Drugs 0.000 description 1
229910000157 magnesium phosphate Inorganic materials 0.000 description 1
235000010994 magnesium phosphates Nutrition 0.000 description 1
229940072082 magnesium salicylate Drugs 0.000 description 1
MYUGVHJLXONYNC-QHTZZOMLSA-L magnesium;(2s)-2-amino-5-hydroxy-5-oxopentanoate Chemical compound [Mg+2].[O-]C(=O)[C@@H](N)CCC(O)=O.[O-]C(=O)[C@@H](N)CCC(O)=O MYUGVHJLXONYNC-QHTZZOMLSA-L 0.000 description 1
CRSJYWPXKKSOCQ-CBAPHJFVSA-L magnesium;(2s)-2-aminobutanedioate;hydron;tetrahydrate Chemical compound O.O.O.O.[Mg+2].[O-]C(=O)[C@@H](N)CC(O)=O.[O-]C(=O)[C@@H](N)CC(O)=O CRSJYWPXKKSOCQ-CBAPHJFVSA-L 0.000 description 1
GMDNUWQNDQDBNQ-UHFFFAOYSA-L magnesium;diformate Chemical compound [Mg+2].[O-]C=O.[O-]C=O GMDNUWQNDQDBNQ-UHFFFAOYSA-L 0.000 description 1
LBYCWLBCHNSWFE-UHFFFAOYSA-L magnesium;pyridine-3-carboxylate Chemical compound [Mg+2].[O-]C(=O)C1=CC=CN=C1.[O-]C(=O)C1=CC=CN=C1 LBYCWLBCHNSWFE-UHFFFAOYSA-L 0.000 description 1
239000000463 material Substances 0.000 description 1
229940029985 mineral supplement Drugs 0.000 description 1
235000020786 mineral supplement Nutrition 0.000 description 1
235000015145 nougat Nutrition 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
150000002894 organic compounds Chemical class 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
239000011148 porous material Substances 0.000 description 1
239000000047 product Substances 0.000 description 1
238000010926 purge Methods 0.000 description 1
239000002994 raw material Substances 0.000 description 1
239000011833 salt mixture Substances 0.000 description 1
235000019643 salty taste Nutrition 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000007787 solid Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000008107 starch Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
150000005846 sugar alcohols Chemical class 0.000 description 1
239000013589 supplement Substances 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
-1 trisilicate Chemical compound 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Nutrition Science (AREA)
Mycology (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Neurology (AREA)
Inorganic Chemistry (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Cardiology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Fodder In General (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Fats And Perfumes (AREA)

NL8802383A 1987-09-28 1988-09-28 Magnesium bevattend toevoegsel voor voedingsmiddelen. NL192500C (nl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
NO874067		1987-09-28
NO874067A NO168563C (no)	1987-09-28	1987-09-28	Anvendelse av en organoleptisk akseptabel blanding av magnesiumsalter som mineraladditiv

Publications (3)

Publication Number	Publication Date
NL8802383A NL8802383A (nl)	1989-04-17
NL192500B NL192500B (nl)	1997-05-01
NL192500C true NL192500C (nl)	1997-09-02

Family

ID=19890268

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL8802383A NL192500C (nl)	1987-09-28	1988-09-28	Magnesium bevattend toevoegsel voor voedingsmiddelen.

Country Status (16)

Country	Link
US (1)	US4959222A (fr)
JP (1)	JPH01108958A (fr)
KR (1)	KR920003525B1 (fr)
CN (1)	CN1033000A (fr)
BE (1)	BE1003302A3 (fr)
DE (1)	DE3832638A1 (fr)
DK (1)	DK169605B1 (fr)
ES (1)	ES2008604A6 (fr)
FI (1)	FI98193C (fr)
FR (1)	FR2620907B1 (fr)
GB (1)	GB2210243B (fr)
IT (1)	IT1225239B (fr)
LU (1)	LU87348A1 (fr)
NL (1)	NL192500C (fr)
NO (1)	NO168563C (fr)
SE (1)	SE501114C2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH01312871A (ja) *	1988-06-10	1989-12-18	Omron Tateisi Electron Co	スリット光用半導体発光ダイオード
DE4201504C2 (de) *	1992-01-21	1997-04-30	Protina Chemische Ges Mbh	Magnesiumpräparat
US5962030A (en)	1997-03-07	1999-10-05	Akesis Pharmaceuticals, Inc.	Dietary supplement and method of treatment for diabetic control
US6162464A (en) *	1997-03-31	2000-12-19	Inkine Pharmaceutical, Inc.	Non-aqueous colonic purgative formulations
DE19811167A1 (de) *	1998-03-14	1999-09-16	Findusfit Sportdiaetetika Gmbh	Tablette, Lutschtablette zur Kohlenhydratversorgung mit Langzeitwirkung
US6376549B1 (en) *	1998-09-17	2002-04-23	Akesis Pharmaceuticals, Inc.	Metforimin-containing compositions for the treatment of diabetes
EP1113804A2 (fr)	1998-09-17	2001-07-11	Akesis Pharmaceuticals, Inc.	Compositions et traitements contre les troubles du metabolisme du glucose
CN1074265C (zh) *	1999-03-19	2001-11-07	王晓忠	制备冻腐竹的方法
GB0028238D0 (en) *	2000-11-20	2001-01-03	Cerestar Holding Bv	Indigestible oligosaccharides and magnesium absorption in humans
WO2002082928A1 (fr) *	2001-04-13	2002-10-24	Joosin R & D Co., Ltd.	Complement alimentaire dietetique pour le traitement et la prevention de la constipation
CA2459830C (fr) *	2001-09-19	2009-09-01	Maruo Calcium Company Limited	Composition sous forme de poudre ou de bouillie, d'additif alimentaire contenant du magnesium
US9707253B2 (en) *	2008-05-19	2017-07-18	Pharmalyte Solutions, Llc	High-loading, controlled-release magnesium oral dosage forms and methods for making and using same
EP3563838A1 (fr)	2013-03-15	2019-11-06	Braintree Laboratories, Inc.	Comprimés de composition pharmaceutique orale à double utilisation de sels de sulfate et leurs procédés d'utilisation
EP3338772A1 (fr)	2016-12-22	2018-06-27	Merz Pharma GmbH & Co. KGaA	Compositions avec trimagnesiumdicittrate stabilise par acides hydroxycarboxyliques , leurs production et compositions concentrees de magnesium
KR102135463B1 (ko) *	2020-01-23	2020-07-17	주식회사 하이테크글로벌	활성 천연 미네랄을 포함하는 항생제 대체물질

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2816854A (en) *	1953-05-26	1957-12-17	Ralph H Gross	Nutrition aid
US3624201A (en) *	1968-02-12	1971-11-30	Lescarden Ltd	Compositions containing calcium and magnesium salts of citric, phosphoric and lactic acid and method of promoting healing of wounds therewith
ZA715005B (en) *	1970-08-27	1972-04-26	Richardson Merrell Inc	Concentrated antacid composition
US4202887A (en) *	1977-06-27	1980-05-13	Redel, Inc.	Livestock feed supplement
JPS5832857B2 (ja) *	1981-02-23	1983-07-15	南日本酪農協同株式会社	熱凝固性乳蛋白質の製法
EP0125252A1 (fr) *	1982-11-16	1984-11-21	MOTSCHAN, Georges	Nouvelle utilisation d'une vitamine unique ou d'une combinaison de diverses vitamines
EP0174192A3 (fr) *	1984-09-05	1987-04-22	Minaminihion Rakuno Kyodo Kabushiki Kaisha	Procédé de préparation d'une protéine du lait résistante à la chaleur ayant une bonne aptitude au traitement et/ou une bonne résistance aux acides et aux bases, et un produit alimentaire contenant cette protéine
US4582709A (en) *	1985-02-08	1986-04-15	Warner-Lambert Company	Chewable mineral supplement
BE902690A (fr) *	1985-06-18	1985-10-16	Cederroth Nordic Ab	Melange de sels mineraux.
EP0208805A1 (fr) *	1985-07-19	1987-01-21	Socop Nahrungsmittel Gmbh	Procédé de production de cytorrhysates thallophytiques ou bryophytiques, chemicytorrhysates ainsi produits et leur utilisation à titre de substances alimentaires additionnées

1987
- 1987-09-28 NO NO874067A patent/NO168563C/no not_active IP Right Cessation
1988
- 1988-09-20 DK DK523388A patent/DK169605B1/da not_active IP Right Cessation
- 1988-09-21 FI FI884326A patent/FI98193C/fi not_active IP Right Cessation
- 1988-09-21 GB GB8822217A patent/GB2210243B/en not_active Expired - Fee Related
- 1988-09-23 US US07/248,419 patent/US4959222A/en not_active Expired - Fee Related
- 1988-09-26 DE DE3832638A patent/DE3832638A1/de active Granted
- 1988-09-27 LU LU87348A patent/LU87348A1/de unknown
- 1988-09-27 CN CN88107933A patent/CN1033000A/zh active Pending
- 1988-09-27 ES ES8802928A patent/ES2008604A6/es not_active Expired
- 1988-09-27 SE SE8803409A patent/SE501114C2/sv not_active IP Right Cessation
- 1988-09-27 FR FR888812873A patent/FR2620907B1/fr not_active Expired - Fee Related
- 1988-09-27 JP JP63239882A patent/JPH01108958A/ja active Granted
- 1988-09-27 IT IT8809491A patent/IT1225239B/it active
- 1988-09-28 BE BE8801111A patent/BE1003302A3/fr not_active IP Right Cessation
- 1988-09-28 NL NL8802383A patent/NL192500C/nl not_active IP Right Cessation
- 1988-09-28 KR KR1019880012537A patent/KR920003525B1/ko not_active Expired

Also Published As

Publication number	Publication date
DK523388D0 (da)	1988-09-20
CN1033000A (zh)	1989-05-24
LU87348A1 (de)	1989-04-06
NO874067L (no)	1989-03-29
FR2620907B1 (fr)	1992-11-27
IT8809491A0 (it)	1988-09-27
FI98193B (fi)	1997-01-31
KR920003525B1 (ko)	1992-05-02
NO874067D0 (no)	1987-09-28
US4959222A (en)	1990-09-25
NL8802383A (nl)	1989-04-17
DK523388A (da)	1989-03-29
FI98193C (fi)	1997-05-12
IT1225239B (it)	1990-11-02
SE8803409L (sv)	1989-03-29
ES2008604A6 (es)	1989-07-16
BE1003302A3 (fr)	1992-02-25
FI884326A0 (fi)	1988-09-21
DK169605B1 (da)	1994-12-27
SE8803409D0 (sv)	1988-09-27
JPH01108958A (ja)	1989-04-26
NL192500B (nl)	1997-05-01
DE3832638A1 (de)	1989-04-06
GB2210243B (en)	1991-11-27
NO168563C (no)	1992-03-11
FR2620907A1 (fr)	1989-03-31
NO168563B (no)	1991-12-02
SE501114C2 (sv)	1994-11-21
JPH0475748B2 (fr)	1992-12-01
DE3832638C2 (fr)	1991-06-06
GB8822217D0 (en)	1988-10-26
FI884326L (fi)	1989-03-29
GB2210243A (en)	1989-06-07
KR900004273A (ko)	1990-04-12

Legal Events

Date	Code	Title	Description
1992-09-01	BA	A request for search or an international-type search has been filed
1992-10-01	BB	A search report has been drawn up
1992-12-01	BC	A request for examination has been filed
2001-06-01	V1	Lapsed because of non-payment of the annual fee	Effective date: 20010401

Publication	Publication Date	Title
NL192500C (nl)	1997-09-02	Magnesium bevattend toevoegsel voor voedingsmiddelen.
JP3381002B2 (ja)	2003-02-24	精製されたプロポリス抽出物とその製造方法並びに用途
JP4273277B2 (ja)	2009-06-03	オリゴ糖補給組成物
US4650669A (en)	1987-03-17	Method to make effervescent calcium tablets and calcium tablets produced thereby
US20130302387A1 (en)	2013-11-14	Compositions and Formulations for the Treatment of Halitosis
EP0914315B1 (fr)	2001-04-11	Sels stables et non hygroscopiques de l(-)carnitine et de derives alcanoyles de l(-)carnitine, procede de preparation de ces sels et compositions solides contenant ces sels et pouvant etre administrees oralement
JPH05507692A (ja)	1993-11-04	カルシウムシトレートマレート組成物
DE69906651T2 (de)	2003-12-18	Zusammensetzungen mit langsamer Freigabe enthaltend eine Zinkverbindung und Vitamin C-Derivate
JP2001515019A5 (fr)	2006-01-05
CA2434927C (fr)	2011-10-18	Compositions pharmaceutiques a activite antibiotique
JPS58501590A (ja)	1983-09-22	ビスマス含有組成物及び該組成物の製造方法
JPH06505498A (ja)	1994-06-23	咀嚼性制酸組成物
KR0143232B1 (ko)	1998-07-15	철 공급용 제제, 비타민 공급용 제제 및 발포 제제의 안정화 방법
JP5290975B2 (ja)	2013-09-18	Ｌ−カルニチンフマル酸カルシウム及びその製造方法と用途
US6203827B1 (en)	2001-03-20	Composition containing readily absorbable calcium and process for producing the same
JP4951226B2 (ja)	2012-06-13	α−リポ酸アルカリ塩の製法
WO2001001992A1 (fr)	2001-01-11	Preparation solide de sulfate de glucosamine
JPH09502709A (ja)	1997-03-18	エストロン誘導体及びカルシウム塩含有の経口、水溶性製薬組成物
US20040220266A1 (en)	2004-11-04	Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
JPH0947253A (ja)	1997-02-18	易吸収性カルシウムを含有する組成物およびその製造方法
JP2000044469A (ja)	2000-02-15	内服液剤
JP2616822B2 (ja)	1997-06-04	カルシウム製剤
KR100825572B1 (ko)	2008-04-25	칼슘, 마그네슘 및 비타민을 포함하는 액제 조성물 및 그의제조방법
WO2001001993A1 (fr)	2001-01-11	Preparation de sulfate de glucosamine
RU2313350C1 (ru)	2007-12-27	Способ повышения растворимости кальция сукцината, кальция малата и кальция цитрата для детских лекарственных форм